PARP inhibitor Iniparib, Purity ≥98%

Cat. No.: X23-10-ZQ229

PARP inhibitor Iniparib, Purity ≥98%

Synonym: 160003-66-7; 4-Iodo-3-nitrobenzamide; Iniparib; BSI-201; Iniparib (BSI-201); BSI 201; 4-Iodo-3-nitro-Benzamide; 4-oxo-1,4-Dihydro-quinoline-6-carboxylicacid; PARP inhibitor

  • MDL: MFCD11110639
  • CAS Number: 160003-66-7
  • Compound CID: 9796068
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Iniparib, soluble in DMSO and ethanol and insoluble in water, binds to the PARP enzyme's active site, preventing it from repairing single-strand DNA breaks. It targets PARP1.
Molecular Weight
292
Molecular Formula
C7H5IN2O3
Targets
PARP1
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 53 mg/mL (181.48 mM); Water: Insoluble; Ethanol: 25 mg/mL (85.61 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Iniparib can be used to study its function as a PARP inhibitor in cancer therapy research.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0